- ►nih.gov P Holvoet, DH Lee, M Steffes, M Gross, DR … - Jama, 2008 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Context Experimental data ... Cited by 28 - Related articles - BL Direct - All 9 versions
G Musso, R Gambino, M Cassader - Progress in Lipid Research, 2009 - Elsevier Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver
disease in Western countries and is considered the hepatic manifestation of
metabolic syndrome. The hallmark of NAFLD is hepatic neutral lipid ... Cited by 7 - Related articles - All 2 versions
T Kanda, JD Brown, G Orasanu, S Vogel, FJ … - The Journal of Clinical Investigation, 2009 - pubmedcentral.nih.gov Although endothelial dysfunction, defined as abnormal vasoreactivity, is a
common early finding in individuals with type 2 diabetes, the endothelium has
not been known to regulate metabolism. As PPARγ, a transcriptional ... Cited by 6 - Related articles - All 7 versions
J Hsieh, AA Hayashi, J Webb, K Adeli - Atherosclerosis (Supplements)(Component), 2008 - Elsevier Insulin resistance is strongly associated with metabolic dyslipidemia, which is
largely a postprandial phenomenon. Though previously regarded as a consequence
of delayed triglyceride-rich lipoprotein clearance, emerging evidence ... Cited by 4 - Related articles - All 25 versions
- ►jbc.org L Qiao, C Zou, P Shao, J Schaack, PF … - Journal of Biological Chemistry, 2008 - ASBMB Fatty acid translocase (FAT/CD36) plays an important role in facilitating long
chain fatty acid transport. FAT/CD36 gene deletion protects mice from high fat
diet-induced obesity. In this study we have investigated the regulatory ... Cited by 4 - Related articles - All 4 versions
S Wada, T Yamazaki, Y Kawano, S Miura, O … - Journal of Hepatology, 2008 - Elsevier In mice fed safflower oil, ethanol increased liver TG 3-fold, with activation of
SREBP-1c and ChREBP, which promote de novo lipogenesis, and increases in
expression of mRNAs for PPARγ and DGATs mRNAs, which promote TG synthesis. ... Cited by 2 - Related articles - All 18 versions
CZ Larter, MM Yeh, DM Van Rooyen, NC Teoh, … - Journal of Gastroenterology and Hepatology, 2009 - pt.wkhealth.com Results:: After 12 weeks HF-feeding, foz/foz mice were obese and diabetic with
approximately 70% reduction in serum adiponectin. Hepatomegaly developed at this
time, corresponding to a plateau in adipose expansion and increased adipose ... Cited by 1 - Related articles - All 4 versions
- ►nih.gov P Holvoet, D De Keyzer, DR Jacobs Jr - Future Lipidol., 2008 - Future Medicine The metabolic syndrome is a common and complex disorder combining obesity,
dyslipidemia, hypertension and insulin resistance. It is associated with a high
cardiovascular risk that can only partially be explained by its components. ... Cited by 1 - Related articles - All 18 versions
M Wierzbicki, A Chabowski, M Zendzian- … - JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2009 - jpp.krakow.pl Long chain fatty acids (LCFAs) on their way from the microvascular compartment
to the hepatocytes, first have to pass the capillary endothelium. As outlined in
more details elsewhere, in the liver, unlike other tissues such as skeletal ... Related articles - View as HTML - All 2 versions
M Schreurs, F Kuipers, FR van der Leij - Obesity reviews: an official journal of the International …, 2009 - interscience.wiley.com Insulin sensitizers like metformin generally act through pathways triggered by
adenosine monophosphate-activated protein kinase. Carnitine palmitoyltransferase
1 (CPT1) controls mitochondrial β-oxidation and is inhibited by ... Related articles - All 2 versions
